PTC Therapeutics director Michael Schmertzler reports $158,653 common share sale

PUBT · 1d ago
PTC Therapeutics director Michael Schmertzler reports $158,653 common share sale
  • PTC Therapeutics director Michael Schmertzler disclosed sales of 2,500 common shares on Oct. 7, 2026.
  • Shares were sold at USD 63.38 and USD 63.95.
  • Indirect stake fell to 1,294,094 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTC Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001288952-26-000014), on October 09, 2026, and is solely responsible for the information contained therein.